Connect with us

Health

See How To Spot Original And Fake, As NAFDAC Warns Against Postinor-2 Pills Circulating In Nigeria

Published

on

NAFDAC, the National Agency for Food and Drug Administration and Control, has warned Nigerians about the circulation of fake Postinor-2 emergency contraceptive pills.

In a statement signed by Director-General Mojisola Adeyeye, NAFDAC revealed that the counterfeit pills were reported by the Society for Family Health (SFH), the official distributor of Postinor-2 in Nigeria, which confirmed that the suspicious batches were not imported by the company.

How to Detect Fake Postinor-2 Pills

According to NAFDAC, fake Postinor-2 can be identified through these packaging errors;

  • Smaller font size on the PIN verification sticker.
  • Wrong spelling of the word “verify.”
  • Wrong spelling of “distributed” at the back of the pack.
  • The agency listed two falsified batches currently in circulation;
  • Type 1: Batch number T36184B; MFG date: 08/2024; EXP date: 08/2028; NRN: 04-698.
  • Type 2: Batch number 332; MFG date: 03/2023; EXP date: 02/2027; NRN: 04-698.

Health Risks of Fake Postinor-2

NAFDAC warned that taking counterfeit Postinor-2 may cause;

  • Failure of contraceptive effect.
  • Exposure to toxic or harmful contaminants.
  • Unpredictable side effects.
  • Missed opportunity for genuine emergency contraception.
  • Long-term reproductive health issues.
  • The agency also cautioned that extreme reactions could include allergic responses, organ damage, or even death.

NAFDAC’s Safety Advice

NAFDAC stressed that counterfeit drugs are unsafe, untested, and illegal. To stay safe, Nigerians are urged to;

  • Buy Postinor-2 only from verified pharmacies and licensed healthcare providers.
  • Check the packaging carefully before use.
  • Report suspicious products to NAFDAC immediately.

The agency confirmed ongoing investigations to trace the source of the counterfeit drugs and has directed state coordinators to remove fake Postinor-2 from circulation.

Distributors, pharmacists, and healthcare workers are also urged to maintain vigilance and ensure that all medical products come from authorised suppliers.